Sudafed Xylometazoline

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Xylometazoline hydrochloride 1 mg/mL

Commercializzato da:

JNTL Consumer Health (New Zealand) Limited

Dosaggio:

1 mg/mL

Forma farmaceutica:

Nasal spray solution

Composizione:

Active: Xylometazoline hydrochloride 1 mg/mL Excipient: Dexpanthenol Dibasic sodium phosphate dodecahydrate Monobasic potassium phosphate Nitrogen Water for injection

Tipo di ricetta:

Pharmacy only

Indicazioni terapeutiche:

Temporary relief from nasal congestion due to colds, influenza, allergic rhinitis and sinusitis

Dettagli prodotto:

Package - Contents - Shelf Life: Spray bottle, plastic, metered, White PE multidose bottle with Ursatec 3K system nasal spray - 10 mL - 36 months from date of manufacture stored at or below 25°C 6 months opened stored at or below 25°C - Spray bottle, plastic, metered, 2 x 10 mL - 20 mL - 36 months from date of manufacture stored at or below 25°C 6 months opened stored at or below 25°C

Data dell'autorizzazione:

2017-06-02